Schubert & CO Amgen Inc Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $9,031 - $11,008	-40 Reduced 30.77%	90 $21,000
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $4,351 - $5,529	19 Added 17.12%	130 $34,000
Q3 2022 Oct 21, 2022	BUY	$224.46 - $253.15 $3,366 - $3,797	15 Added 15.63%	111 $25,000
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $12,227 - $13,607	53 Added 123.26%	96 $23,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1,973 - $2,183	9 Added 26.47%	43 $10,000
Q4 2021 Jan 28, 2022	BUY	$198.88 - $227.6 $6,761 - $7,738	34 New	34 $8,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.